Loading…
Time to Systemic Metastases in Patients with Posterior Uveal Melanoma
A total of 116 patients, all of whom had systemic metastases from posterior uveal melanoma, were evaluated to identify potential indicators for time to systemic metastasis. In the multivariate Cox proportional hazards model with clinically available variables, the age at initial treatment for uveal...
Saved in:
Published in: | Cancer investigation 1997, Vol.15 (2), p.98-105 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c430t-8c495982af7c306316f965a5b18861ba6ec5c2fbc2d6130ce23a8b52bba3be993 |
---|---|
cites | cdi_FETCH-LOGICAL-c430t-8c495982af7c306316f965a5b18861ba6ec5c2fbc2d6130ce23a8b52bba3be993 |
container_end_page | 105 |
container_issue | 2 |
container_start_page | 98 |
container_title | Cancer investigation |
container_volume | 15 |
creator | Sato, Takami Babazono, Akira Shields, Jerry A. Shields, Carol L. Potter, Patrick De Mastrangelo, Michael J. |
description | A total of 116 patients, all of whom had systemic metastases from posterior uveal melanoma, were evaluated to identify potential indicators for time to systemic metastasis. In the multivariate Cox proportional hazards model with clinically available variables, the age at initial treatment for uveal melanoma, gender and diameter of the primary tumor were revealed to be independent predictive factors for time to systemic metastasis. Age older than 60 years, male gender, and diameter of the primary uveal melanoma more than 10 mm were proved to be independent unfavorable factors. The estimated median time to systemic metastasis for the most unfavorable group (age >60, male, diameter >10 mm) was 20.2 months in contrast with 76.1 months for the most favorable group (age < 60, female, diameter < 10 mm). Although the results of this study cannot be applied to all patients with posterior uveal melanoma, predictive factors for time to systemic metastasis in those patients who have recurred supplement the information obtained from prognostic factors for the likelihood of metastasis or suivival. They contribute not only to our understanding of the biology of metastasizing posterior uveal melanoma, but also in developing appropriate strategies for follow-up and treatment. |
doi_str_mv | 10.3109/07357909709115761 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmed_primary_9095204</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>78911048</sourcerecordid><originalsourceid>FETCH-LOGICAL-c430t-8c495982af7c306316f965a5b18861ba6ec5c2fbc2d6130ce23a8b52bba3be993</originalsourceid><addsrcrecordid>eNp9kMtKAzEUhoMotV4ewIUwC3E3msskmaAbKd5AsWC7Hs6kGRqZmWiSWvr2prQKIgiBLP7vP5zzIXRC8AUjWF1iybhUWEmsCOFSkB00JJzRvCCK7qLhOs8TIPfRQQhvGJOSSj5Ag9ThFBdDdDuxncmiy15XIZrO6uzZRAjpmZDZPhtDtKaPIVvaOM_GLkHeOp9NPw20iW2hdx0cob0G2mCOt_8hmt7dTkYP-dPL_ePo5inXBcMxL3WhuCopNFIzLBgRjRIceE3KUpAahNFc06bWdCYIw9pQBmXNaV0Dq41S7BCdb-a-e_exMCFWnQ3atGkL4xahkmXygIsygWQDau9C8Kap3r3twK8qgqu1uuqPutQ53Q5f1J2Z_TS2rlJ-ts0haGgbD7224QejgmEmRcKuN5jtG-c7WDrfzqoIq9b57w77b4urX_V58hznGryp3tzC90nvPzd8AY9mmrU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78911048</pqid></control><display><type>article</type><title>Time to Systemic Metastases in Patients with Posterior Uveal Melanoma</title><source>Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list)</source><creator>Sato, Takami ; Babazono, Akira ; Shields, Jerry A. ; Shields, Carol L. ; Potter, Patrick De ; Mastrangelo, Michael J.</creator><creatorcontrib>Sato, Takami ; Babazono, Akira ; Shields, Jerry A. ; Shields, Carol L. ; Potter, Patrick De ; Mastrangelo, Michael J.</creatorcontrib><description>A total of 116 patients, all of whom had systemic metastases from posterior uveal melanoma, were evaluated to identify potential indicators for time to systemic metastasis. In the multivariate Cox proportional hazards model with clinically available variables, the age at initial treatment for uveal melanoma, gender and diameter of the primary tumor were revealed to be independent predictive factors for time to systemic metastasis. Age older than 60 years, male gender, and diameter of the primary uveal melanoma more than 10 mm were proved to be independent unfavorable factors. The estimated median time to systemic metastasis for the most unfavorable group (age >60, male, diameter >10 mm) was 20.2 months in contrast with 76.1 months for the most favorable group (age < 60, female, diameter < 10 mm). Although the results of this study cannot be applied to all patients with posterior uveal melanoma, predictive factors for time to systemic metastasis in those patients who have recurred supplement the information obtained from prognostic factors for the likelihood of metastasis or suivival. They contribute not only to our understanding of the biology of metastasizing posterior uveal melanoma, but also in developing appropriate strategies for follow-up and treatment.</description><identifier>ISSN: 0735-7907</identifier><identifier>EISSN: 1532-4192</identifier><identifier>DOI: 10.3109/07357909709115761</identifier><identifier>PMID: 9095204</identifier><identifier>CODEN: CINVD7</identifier><language>eng</language><publisher>New York, NY: Informa UK Ltd</publisher><subject>Analysis of Variance ; Biological and medical sciences ; Female ; Follow-Up Studies ; Humans ; Male ; Medical sciences ; Melanoma - pathology ; Melanoma - secondary ; Melanoma - therapy ; Middle Aged ; Neoplasm Metastasis ; Ophthalmology ; Proportional Hazards Models ; Time Factors ; Tumors and pseudotumors of the eye, orbit, eyelid, lacrimal apparatus ; Uveal Neoplasms - pathology ; Uveal Neoplasms - therapy</subject><ispartof>Cancer investigation, 1997, Vol.15 (2), p.98-105</ispartof><rights>1997 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 1997</rights><rights>1997 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c430t-8c495982af7c306316f965a5b18861ba6ec5c2fbc2d6130ce23a8b52bba3be993</citedby><cites>FETCH-LOGICAL-c430t-8c495982af7c306316f965a5b18861ba6ec5c2fbc2d6130ce23a8b52bba3be993</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4024,27923,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2630376$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9095204$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sato, Takami</creatorcontrib><creatorcontrib>Babazono, Akira</creatorcontrib><creatorcontrib>Shields, Jerry A.</creatorcontrib><creatorcontrib>Shields, Carol L.</creatorcontrib><creatorcontrib>Potter, Patrick De</creatorcontrib><creatorcontrib>Mastrangelo, Michael J.</creatorcontrib><title>Time to Systemic Metastases in Patients with Posterior Uveal Melanoma</title><title>Cancer investigation</title><addtitle>Cancer Invest</addtitle><description>A total of 116 patients, all of whom had systemic metastases from posterior uveal melanoma, were evaluated to identify potential indicators for time to systemic metastasis. In the multivariate Cox proportional hazards model with clinically available variables, the age at initial treatment for uveal melanoma, gender and diameter of the primary tumor were revealed to be independent predictive factors for time to systemic metastasis. Age older than 60 years, male gender, and diameter of the primary uveal melanoma more than 10 mm were proved to be independent unfavorable factors. The estimated median time to systemic metastasis for the most unfavorable group (age >60, male, diameter >10 mm) was 20.2 months in contrast with 76.1 months for the most favorable group (age < 60, female, diameter < 10 mm). Although the results of this study cannot be applied to all patients with posterior uveal melanoma, predictive factors for time to systemic metastasis in those patients who have recurred supplement the information obtained from prognostic factors for the likelihood of metastasis or suivival. They contribute not only to our understanding of the biology of metastasizing posterior uveal melanoma, but also in developing appropriate strategies for follow-up and treatment.</description><subject>Analysis of Variance</subject><subject>Biological and medical sciences</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Melanoma - pathology</subject><subject>Melanoma - secondary</subject><subject>Melanoma - therapy</subject><subject>Middle Aged</subject><subject>Neoplasm Metastasis</subject><subject>Ophthalmology</subject><subject>Proportional Hazards Models</subject><subject>Time Factors</subject><subject>Tumors and pseudotumors of the eye, orbit, eyelid, lacrimal apparatus</subject><subject>Uveal Neoplasms - pathology</subject><subject>Uveal Neoplasms - therapy</subject><issn>0735-7907</issn><issn>1532-4192</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><recordid>eNp9kMtKAzEUhoMotV4ewIUwC3E3msskmaAbKd5AsWC7Hs6kGRqZmWiSWvr2prQKIgiBLP7vP5zzIXRC8AUjWF1iybhUWEmsCOFSkB00JJzRvCCK7qLhOs8TIPfRQQhvGJOSSj5Ag9ThFBdDdDuxncmiy15XIZrO6uzZRAjpmZDZPhtDtKaPIVvaOM_GLkHeOp9NPw20iW2hdx0cob0G2mCOt_8hmt7dTkYP-dPL_ePo5inXBcMxL3WhuCopNFIzLBgRjRIceE3KUpAahNFc06bWdCYIw9pQBmXNaV0Dq41S7BCdb-a-e_exMCFWnQ3atGkL4xahkmXygIsygWQDau9C8Kap3r3twK8qgqu1uuqPutQ53Q5f1J2Z_TS2rlJ-ts0haGgbD7224QejgmEmRcKuN5jtG-c7WDrfzqoIq9b57w77b4urX_V58hznGryp3tzC90nvPzd8AY9mmrU</recordid><startdate>1997</startdate><enddate>1997</enddate><creator>Sato, Takami</creator><creator>Babazono, Akira</creator><creator>Shields, Jerry A.</creator><creator>Shields, Carol L.</creator><creator>Potter, Patrick De</creator><creator>Mastrangelo, Michael J.</creator><general>Informa UK Ltd</general><general>Taylor & Francis</general><general>Informa Healthcare</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>1997</creationdate><title>Time to Systemic Metastases in Patients with Posterior Uveal Melanoma</title><author>Sato, Takami ; Babazono, Akira ; Shields, Jerry A. ; Shields, Carol L. ; Potter, Patrick De ; Mastrangelo, Michael J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c430t-8c495982af7c306316f965a5b18861ba6ec5c2fbc2d6130ce23a8b52bba3be993</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Analysis of Variance</topic><topic>Biological and medical sciences</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Melanoma - pathology</topic><topic>Melanoma - secondary</topic><topic>Melanoma - therapy</topic><topic>Middle Aged</topic><topic>Neoplasm Metastasis</topic><topic>Ophthalmology</topic><topic>Proportional Hazards Models</topic><topic>Time Factors</topic><topic>Tumors and pseudotumors of the eye, orbit, eyelid, lacrimal apparatus</topic><topic>Uveal Neoplasms - pathology</topic><topic>Uveal Neoplasms - therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sato, Takami</creatorcontrib><creatorcontrib>Babazono, Akira</creatorcontrib><creatorcontrib>Shields, Jerry A.</creatorcontrib><creatorcontrib>Shields, Carol L.</creatorcontrib><creatorcontrib>Potter, Patrick De</creatorcontrib><creatorcontrib>Mastrangelo, Michael J.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer investigation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sato, Takami</au><au>Babazono, Akira</au><au>Shields, Jerry A.</au><au>Shields, Carol L.</au><au>Potter, Patrick De</au><au>Mastrangelo, Michael J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Time to Systemic Metastases in Patients with Posterior Uveal Melanoma</atitle><jtitle>Cancer investigation</jtitle><addtitle>Cancer Invest</addtitle><date>1997</date><risdate>1997</risdate><volume>15</volume><issue>2</issue><spage>98</spage><epage>105</epage><pages>98-105</pages><issn>0735-7907</issn><eissn>1532-4192</eissn><coden>CINVD7</coden><abstract>A total of 116 patients, all of whom had systemic metastases from posterior uveal melanoma, were evaluated to identify potential indicators for time to systemic metastasis. In the multivariate Cox proportional hazards model with clinically available variables, the age at initial treatment for uveal melanoma, gender and diameter of the primary tumor were revealed to be independent predictive factors for time to systemic metastasis. Age older than 60 years, male gender, and diameter of the primary uveal melanoma more than 10 mm were proved to be independent unfavorable factors. The estimated median time to systemic metastasis for the most unfavorable group (age >60, male, diameter >10 mm) was 20.2 months in contrast with 76.1 months for the most favorable group (age < 60, female, diameter < 10 mm). Although the results of this study cannot be applied to all patients with posterior uveal melanoma, predictive factors for time to systemic metastasis in those patients who have recurred supplement the information obtained from prognostic factors for the likelihood of metastasis or suivival. They contribute not only to our understanding of the biology of metastasizing posterior uveal melanoma, but also in developing appropriate strategies for follow-up and treatment.</abstract><cop>New York, NY</cop><pub>Informa UK Ltd</pub><pmid>9095204</pmid><doi>10.3109/07357909709115761</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0735-7907 |
ispartof | Cancer investigation, 1997, Vol.15 (2), p.98-105 |
issn | 0735-7907 1532-4192 |
language | eng |
recordid | cdi_pubmed_primary_9095204 |
source | Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list) |
subjects | Analysis of Variance Biological and medical sciences Female Follow-Up Studies Humans Male Medical sciences Melanoma - pathology Melanoma - secondary Melanoma - therapy Middle Aged Neoplasm Metastasis Ophthalmology Proportional Hazards Models Time Factors Tumors and pseudotumors of the eye, orbit, eyelid, lacrimal apparatus Uveal Neoplasms - pathology Uveal Neoplasms - therapy |
title | Time to Systemic Metastases in Patients with Posterior Uveal Melanoma |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T02%3A54%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Time%20to%20Systemic%20Metastases%20in%20Patients%20with%20Posterior%20Uveal%20Melanoma&rft.jtitle=Cancer%20investigation&rft.au=Sato,%20Takami&rft.date=1997&rft.volume=15&rft.issue=2&rft.spage=98&rft.epage=105&rft.pages=98-105&rft.issn=0735-7907&rft.eissn=1532-4192&rft.coden=CINVD7&rft_id=info:doi/10.3109/07357909709115761&rft_dat=%3Cproquest_pubme%3E78911048%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c430t-8c495982af7c306316f965a5b18861ba6ec5c2fbc2d6130ce23a8b52bba3be993%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=78911048&rft_id=info:pmid/9095204&rfr_iscdi=true |